EIF2A and melanoma: The enhanced phosphorylation of eIF2α was observed in melanoma cells due to the treatment of tunicamycin and NGLY1 knockdown (Supplementary Figure S2F), indicating the activation of the eIF2α signalling as the upstream of ATF4.